24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

NCT07549646 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Ras/MAPK Pathway Vascular Anomalies
Vascular Anomalies
Vascular Anomaly

Interventions

DRUG: Trametinib

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]